In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
As of close of business last night, Beta Bionics Inc’s stock clocked out at $18.47, down -11.96% from its previous closing price of $20.98. In other words, the price has decreased by -$11.96 from its previous closing price. On the day, 0.58 million shares were traded.
Ratios:
To gain a deeper understanding of BBNX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.99 and its Current Ratio is at 4.62. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.18.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stifel on February 24, 2025, initiated with a Buy rating and assigned the stock a target price of $25.
On February 24, 2025, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $26.
On February 24, 2025, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $28.Leerink Partners initiated its Outperform rating on February 24, 2025, with a $28 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 31 ’25 when Mensinger Mike bought 33,350 shares for $17.00 per share. The transaction valued at 566,950 led to the insider holds 59,019 shares of the business.
Mensinger Mike sold 13 shares of BBNX for $221 on Jan 31 ’25. The Chief Product Officer now owns 25,669 shares after completing the transaction at $17.00 per share. On Jan 31 ’25, another insider, Wellington Hadley Harbor Aggre, who serves as the 10% Owner of the company, bought 1,000,000 shares for $17.00 each. As a result, the insider paid 17,000,000 and bolstered with 3,901,599 shares of the company.
Stock Price History:
Over the past 52 weeks, BBNX has reached a high of $24.50, while it has fallen to a 52-week low of $18.67. The 50-Day Moving Average of the stock is -14.86%, while the 200-Day Moving Average is calculated to be -14.86%.
Shares Statistics:
A total of 42.86M shares are outstanding, with a floating share count of 35.04M. Insiders hold about 19.13% of the company’s shares, while institutions hold 38.04% stake in the company.
Earnings Estimates
The dynamic stock of Beta Bionics Inc (BBNX) is currently being evaluated by a team of 2 analysts, each contributing to its current rating.The consensus estimate for the next quarter is -$0.41, with high estimates of -$0.21 and low estimates of -$0.52.
Analysts are recommending an EPS of between -$1.66 and -$2.63 for the fiscal current year, implying an average EPS of -$2.14. EPS for the following year is -$1.55, with 3.0 analysts recommending between -$0.95 and -$1.88.
Revenue Estimates
For the next quarter, 6 analysts are estimating revenue of $16.89M. There is a high estimate of $22.76M for the next quarter, whereas the lowest estimate is $14.65M.
Based on 7 analysts’ estimates, the company’s revenue will be $85.1M in the next fiscal year. The high estimate is $103.33M and the low estimate is $80.7M.
